Skip to main content
letter
. 2020 Sep 28;93(2):717–718. doi: 10.1002/jmv.26531

Table 1.

Diagnostic parameters analyzed during the development and clinical validation

Diagnostic parameter Definition
Analytical sensitivity/limit of detection Lowest concentration of the analyte that can be reliably detected by the assay.
Analytical specificity Ability of the assay of not cross‐reacting with other pathogens.
Clinical sensitivity Probability the test is positive when the infection is present.
Clinical specificity Probability the test is negative when the infection is absent.
Positive likelihood ratio Ratio between the probability of an infected person testing positive and the probability of an uninfected person testing positive.
Negative likelihood ratio Ratio between the probability of an infected person testing negative and the probability of an uninfected person testing negative.
Positive predictive value (PPV) Probability that the pathogen is present when the test result is positive.
Negative predictive value (NPV) Probability that the pathogen is absent when the test result is negative.
Repeatability Agreement between results of replicates of a sample both within and between runs of the same test in the same laboratory.
Reproducibility Agreement between results of patient specimens assayed in different laboratories.
Robustness Ability of the test to remain unaffected by minor variations that may occur during the testing process.
Accuracy Overall probability that the patient is correctly diagnosed by the test.